SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-046031
Filing Date
2018-07-19
Accepted
2018-07-19 16:34:13
Documents
8
Period of Report
2018-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-17399_18k.htm 8-K 51842
2 EX-2.1 a18-17399_1ex2d1.htm EX-2.1 1862487
3 EX-10.1 a18-17399_1ex10d1.htm EX-10.1 291537
4 EX-10.2 a18-17399_1ex10d2.htm EX-10.2 112081
5 EX-99.1 a18-17399_1ex99d1.htm EX-99.1 20876
6 GRAPHIC g173991kc32ai001.jpg GRAPHIC 2096
7 GRAPHIC g173991kc33i001.gif GRAPHIC 3971
8 GRAPHIC g173991mmi001.jpg GRAPHIC 4524
  Complete submission text file 0001104659-18-046031.txt   2355167
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 18960758
SIC: 2834 Pharmaceutical Preparations